跳至主要内容
临床试验/NCT06801587
NCT06801587已完成4 期

Preemptive Co-infiltration of Triamcinolone Acetonide With Ropivacaine for Postoperative Pain in Patients Undergoing Major Spinal Surgery

Fang Luo1 个研究点 分布在 1 个国家目标入组 118 人开始时间: 2025年2月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
118
试验地点
1
主要终点
The cumulative consumption of sufentanil within 24 hours after spinal surgery via the PCA pump.

研究概览

简要总结

Patients undergoing major spinal surgery usually experience moderate to-severe postoperative pain. Inadequate pain control may lead to severe complications.

Local infiltration analgesia (LIA) with a local anesthetic, is a simple, minimally invasive, and effective postoperative pain management technique. However, LIA with local anesthetic alone can only last for a short time, steroid as adjuvant can enhance postoperative analgesia and prolong postoperative analgesia time. Triamcinolone acetonide as an adjunctive infiltration to local anesthesia presented a superior analgesic benefit compared with local anesthesia alone in various types of surgeries. To date, no studies have evaluated the additive analgesia effects of triamcinolone acetonide on incision infiltration in major spinal surgery. The purpose of this trial is to determine whether preemptive co-infiltration of triamcinolone acetonide and ropivacaine in surgical incision will further reduce postoperative opioid requirements and pain score after spinal surgery than that of ropivacaine alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 18-65 years; Patients scheduled for elective laminoplasty or laminectomy with no more than 3 levels under general anesthesia; American Society of Anesthesiologists (ASA) physical status of I-III; Anticipated full recovery and cooperation within 2 hours postoperatively.

排除标准

  • •History of spinal surgery; Inability to use a patient-controlled analgesia (PCA) pump or comprehend the pain visual analog scale (VAS); Body mass index (BMI)<15kg/m2 or >35kg/m2; Peri-incisional infection; History of diabetes mellitus and other metabolic diseases; History of severe cardiopulmonary, hepatic or renal dysfunction; Preoperative coagulation abnormalities (activated partial thromboplastin time greater than 1.5 times normal value); History of allergies to any of the study drugs; History of alcohol or drugs abuse (more than 2 weeks), or use of any analgesic within 24h before surgery; Use of systemic steroids within 1 week before surgery; History of psychiatric disorders, chronic neck or back pain; History of radiation therapy and chemotherapy or with a high probability of such treatment postoperatively; Pregnant or breastfeeding; Refusal to sign informed consent.

研究组 & 干预措施

Triamcinolone acetonide plus ropivacaine group

Experimental

The local infiltration solution in the triamcinolone acetonide plus ropivacaine group will consist of triamcinolone acetonide and ropivacaine.

干预措施: Triamcinolone acetonide plus ropivacaine (Drug)

The ropivacaine alone group

Active Comparator

The local infiltration solution in the ropivacaine alone group will consist of ropivacaine alone.

干预措施: Ropivacaine alone (Drug)

结局指标

主要结局

The cumulative consumption of sufentanil within 24 hours after spinal surgery via the PCA pump.

时间窗: Within 24 hours after spinal surgery

All participates will receive an electronic intravenous patient-controlled analgesia (PCA) pump. Participates will be advised to push the analgesic demand button if they feel pain

次要结局

  • The cumulative consumption of sufentanil via PCA pump between 24 hours and 48 hours postoperatively.(Between 24 hours and 48 hours after spinal surgery)
  • Number of patients without PCA press button(Within 48 hours after spinal surgery)
  • The time of first PCA demand(Within 48 hours after spinal surgery)
  • The total number of PCA presses including both valid and invalid presses(Within 48 hours after spinal surgery)
  • Postoperative visual analogue scale (VAS) score during movement(VASm)(At 2 hours, 4 hours, 24 hours, 48 hours, 72 hours, 1 week, 2 weeks, 3 weeks, 1 month and 3 months postoperatively)
  • Postoperative VAS score at rest(VASr)(At 2 hours, 4 hours, 24 hours, 48 hours, 72 hours, 1 week, 2 weeks, 3 weeks, 1 month and 3 months postoperatively)
  • Total consumption of Tylenol as supplementary analgesia(Four separate postoperative periods ( 0- postoperative 48 hours, postoperative 48 hours-postoperative 2 weeks, postoperative 2 weeks-postoperative 1 month, and postoperative 1 month-postoperative 3 months))
  • Patient Satisfaction Score (PSS) with pain relief(At 48 hours, 72 hours, 1 week, 2 weeks, 3 weeks 1 month and 3 months postoperatively)
  • Postoperative nausea and vomiting (PONV) score(At 2 hours, 4 hours, 24 hours, 48 hours and 72 hours postoperatively)
  • Patient Scar Assessment and the Observer Scar Assessment Scale (POSAS)(At 2 weeks, 1 month and 3 months postoperatively)
  • Readmission rate within 3 months after spine surgery(Through the whole follow-up, within 3 months after spine surgery)
  • Total consumption of remifentanil during surgery(During surgery)
  • Ramsay Sedation Scale (RSS)(At 2 hours, 4 hours, 24 hours, 48 hours and 72 hours postoperatively)
  • Duration of hospitalization after surgery(Approximately 1-2 weeks after surgery)
  • Rate of steroid-related side effects and complications(Through the whole follow-up, an average of 3 months)
  • Length of Postoperative Anesthesia Care Unit (PACU) stay(Approximately 30 minutes to 2 hours after surgery)
  • Total consumption of loxoprofen(From postoperative 48 hours to approximately 1-2 weeks after surgery)

研究者

发起方
Fang Luo
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Fang Luo

Director of Department of Pain Management

Beijing Tiantan Hospital

研究点 (1)

Loading locations...

相似试验